SLC5A1 and cardiac hypertrophy: In contrast, cardiac overexpression of SGLT1 in mice increased markers of cardiac hypertrophy, glycogen content, and heart ratio, resulting in progressive left ventricular dysfunction, myocyte enlargement, and interstitial fibrosis [3].